N

Nykode Therapeutics ASA
OSE:NYKD

Watchlist Manager
Nykode Therapeutics ASA
OSE:NYKD
Watchlist
Price: 2.168 NOK 1.59% Market Closed
Market Cap: 708m NOK
Have any thoughts about
Nykode Therapeutics ASA?
Write Note

Nykode Therapeutics ASA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Nykode Therapeutics ASA
Total Equity Peer Comparison

Comparables:
HBC
B
BGBIO
L
LYTIX
AZT
T
TRMED

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
N
Nykode Therapeutics ASA
OSE:NYKD
Total Equity
$152.1m
CAGR 3-Years
-3%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Total Equity
kr138.2m
CAGR 3-Years
-14%
CAGR 5-Years
23%
CAGR 10-Years
2%
B
Bergenbio ASA
OSE:BGBIO
Total Equity
kr175.3m
CAGR 3-Years
-30%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Total Equity
kr51.3m
CAGR 3-Years
37%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Total Equity
kr317.5m
CAGR 3-Years
13%
CAGR 5-Years
47%
CAGR 10-Years
11%
T
Thor Medical ASA
OSE:TRMED
Total Equity
kr260m
CAGR 3-Years
-11%
CAGR 5-Years
-8%
CAGR 10-Years
17%

See Also

What is Nykode Therapeutics ASA's Total Equity?
Total Equity
152.1m USD

Based on the financial report for Jun 30, 2024, Nykode Therapeutics ASA's Total Equity amounts to 152.1m USD.

What is Nykode Therapeutics ASA's Total Equity growth rate?
Total Equity CAGR 5Y
32%

Over the last year, the Total Equity growth was 9%. The average annual Total Equity growth rates for Nykode Therapeutics ASA have been -3% over the past three years , 32% over the past five years .

Back to Top